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Introduction
It is estimated that 2 billion people are infected with 
hepatitis B virus (HBV) worldwide, and 350 million 
of them are chronic carriers (1). The prevalence of 
HBV infection has been reported to be different in 
various parts of the developed and developing world 
(1). Turkey has intermediate endemicity for HBV (2). 
The hepatitis B surface antigen (HBsAg) carrier rate 
is 4% (2-8%), while antibody to hepatitis B surface 
antigen (anti-HBs) positivity is 30% (20-55%). On 
average, 40%(30-70%) of patients with chronic liver 
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Background and Aims: Hepatitis B virus (HBV) and Hepatitis C virus (HCV) infections are major worldwide public health 
problems. The objectives of this study were to evaluate the seroprevalence and epidemiological profile of hepatitis B and 
hepatitis C, to determine the impact of the national vaccination programme against hepatitis B on the prevalence of the 
hepatitis B surface antigen (HBsAg) carrier and the antibody to hepatitis B surface antigen (anti-HBs) occurrence rate 
among 0-14 year-old children in southeast Turkey. 
Methods: The seroprevalence of hepatitis B and hepatitis C markers was evaluated retrospectively in a group of 10,391 
children who were admitted to a tertiary hospital, the Diyarbakir Education and Research Hospital, from January 2005 to 
December 2008, in order to obtain a better understanding of the regional hepatitis seroprevalence. Children were divided 
into three different age groups: pre-education period (0-6 years), primary school period (7-12 years) and secondary 
school period (13-14 years). Samples were analyzed for HBsAg, hepatitis B e antigen (HBeAg), antibody to HBeAg (anti-
HBe), anti-HBs positive/antibodies to hepatitis B core antigen (anti-HBc) positive, isolated anti-HBs and antibodies to 
Hepatitis C virus (anti-HCV) using a commercially available enzyme-linked immunosorbent assay (ELISA).
Results: The mean age of all participants was 8.5± 2 years (range, 0-14). The overall percentages for the prevalence of 
HBsAg, HBeAg, anti-HBe and anti-HCV were 8.1%, 2.1%, 5.9% and 0.5%, respectively. HBsAg seroprevalence differed 
significantly by age and gender (P < 0.001). HBeAg seroprevalence was high in the earliest years (P < 0.01). The over-
all prevalence of anti-HCV did not differ significantly by age (P > 0.5) but differed by gender (P < 0.001). The overall 
percentages for the prevalence of isolated anti-HBs and anti-HBs positive/anti-HBc positive were 34.2% and 56.9%, 
respectively. 
Conclusions: Our study sheds new light on hepatitis seroprevalence in southeastern Turkey. For example, 1) The sero-
prevalence of hepatitis B in southeast Turkey is still at its highest rate, according to the averages reported in other stud-
ies conducted in the same and different regions of Turkey; and it has not decreased, as reported previously. 2) HBeAg 
seroprevalence in the earliest years of childhood is high in our study; this is evidence for early acquisition of the infec-
tion. 3) Isolated anti-HBs positive and anti-HBs positive/anti-HBc positive prevalence is high; given these features, it is 
obvious that despite the high incidence of vaccinated children, the prevalence of hepatitis B is increasing; and children 
acquire these viruses in their earliest years. 4) We found the overall prevalence of HCV infection unchanged. Our region 
has a low endemicity for HCV.
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disease are HBsAg positive. 
The  prevalence  of  HBV  infection  and  the 
predominant  mode  of  transmission  vary  greatly 
depending  on  the  geographical  region  and 
epidemiologic factors in Turkey (2, 3). These figures 
are lower in Western Turkey, and much higher in 
East and South-east Turkey where socio-economic 
levels are lower (2). 
Prevention  of  childhood  HBV  infection  has 
a large impact on the prevalence of chronic HBV 
infection and its sequelae (4). In Turkey, the reporting 
of acute viral hepatitis is compulsory and hepatitis B 
vaccine is given at birth to children whose mothers 
are  known  to  be  HBsAg  positive.  Our  country 
has  added  HBV  vaccine  to  its  routine  childhood 
immunization program and has provided it to all 
children since 1997.
There are insufficient data on the seroepidemiology 
of  HBV  infection  in  children  living  in  southeast 
Turkey.  In  this  retrospective  study  we  aimed  at 
determining  the  actual  prevalence  of  hepatitis  B 
and hepatitis C and also the impact of the national 
vaccination program on hepatitis B infection in our 
region, by observing the records of 10,391 children, 
over  a  period  of  4  years  from  January  2005  to 
December 2008. 
Materials and Methods 
Study settings and patients
Diyarbakir  is  the  largest  city  in  southeastern 
Turkey. Situated on the banks of the River Tigris, it 
is the administrative capital of Diyarbakir province, 
with  a  population  of  almost  1.5  million  (5).  The 
Diyarbakir Education and Research Hospital is the 
only and the biggest tertiary state hospital serving 
the  region.  Hepatitis  B  seroprevalence  is  at  its 
highest rate in southeast Turkey, compared to other 
regions  of  Turkey.  Our  study,  which  covered  the 
period  January  2005-December  2008,  was  carried 
out  at  the  Diyarbakir  Education  and  Research 
Hospital, and included children without icterus. In 
addition, none of the children had a history of blood 
transfusion. Informed consent was obtained from 
the children’s parents and/or relatives and this study 
was  approved  by  the  local  health  directorate  and 
the ethics committee of the Diyarbakir Education 
and Research Hospital. The records of a total of 
10,391 applicants were analyzed retrospectively in 
order to determine the seroprevalence of hepatitis 
B and hepatitis C; also the impact of a routine active 
vaccination program on individuals in this endemic 
region was investigated. 
Serological testing
The serological markers of HBsAg, hepatitis B 
e antigen (HBeAg), antibody to HBeAg (anti-HBe), 
antibody to hepatitis B core antigen (anti-HBc), anti-
HBs and antibody to hepatitis C virus (anti-HCV) 
were investigated retrospectively in serum samples 
sent from policlinics and clinics to the microbiology 
laboratory.  In  the  laboratory,  commercial  kits 
based on the enzyme-linked immunosorbent assay 
(ELISA)  E170  (Roche,  Germany)  method  were 
used. Positive samples were subsequently tested for 
hepatitis B virus DNA (HBV-DNA) and hepatitis 
C virus RNA (HCV-RNA) at Hifzisihha National 
Public  Laboratories  using  the  polymerase  chain 
reaction  (PCR)  technique.  In  endemic  regions 
of  Turkey,  vertical  transmission  is  an  important 
route, so we selected the following age groups: pre-
education period (0-6 years), primary school period 
(7-12 years) and secondary school period (13-14 
years).
Statistics
Statistical analysis was carried out by using the 
SPSS 10.0 program. The chi-square test was used 
in  the  statistical  analyses.  ANOVA  was  used  for 
analyzing multiple groups. A value of P < 0.05 was 
considered statistically significant. 
Table 1. Hepatitis seroprevalence by sex and age.
Age Group
Sex 
(Female/Male)
Number of 
tested
HBsAg HBeAg Anti-HBe
Anti-
HCV
Isolated 
anti-HBs
Anti-HBs positive/
Anti-HBc positive
0-6 1260/1901 3721 278 85 193 23 402 961
7-12 1745/2275 3470 423 107 316 12 1301 2655
13-14 1388/1822 3200 141 30 111 18 1857 2300
Total 4393/5998 10391 842 222 620 53 3560 5916Hepatitis Monthly, Winter 2010; 10(1): 36-41
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Results
Retrospectively, applicants totaling 10,391, with 
an average age of 8.5± 2 years (5,998 males (mean 
age 9.3±2 years) and 4,393 females (mean age 7.7±2 
years) were tested for hepatitis B and C markers from 
January 2005 to December 2008 (Table 1). In this 
study, we aimed at determining the seroprevalence of 
hepatitis B and hepatitis C, as well as the frequency of 
HBe/anti-HBe, anti-HBs positive/anti-HBc positive 
and isolated anti-HBs positivity. Our aim was also to 
compare vaccination and environmental health care 
program results among children 0-14 years over a 
period of 4 years. 
The  overall  percentages  for  the  prevalence  of 
HBsAg,  HBeAg,  anti-HBe  and  anti-HCV  were 
8.1%, 2.1%, 5.9% and 0.5%, respectively. As seen in 
Fig. 1, the prevalence of HBsAg and HBeAg has not 
decreased in the region despite the implementation 
of  active  hepatitis  B  vaccine  programs  and 
environmental  health  policies  by  the  Ministry  of 
Health. 
HBeAg seroprevalence was 2.1% overall with a 
considerable increase in children aged ≤12 years (P 
< 0.01) (Fig. 2) but did not differ by gender (P > 
0.05). This shows evidence for early acquisition of 
the infection. We found that the overall prevalence 
of HBsAg differs significantly by gender and age (P 
< 0.001). A higher prevalence of HBsAg was found 
in the 7-12 year-old group and in the male gender (P 
< 0.001).
Fifty  three  (mean  age:  10.1±2  years)  cases,  in 
Figure 1. Seroprevalence of HBsAg, HBe-Ag, anti-HBe and anti-HCV.
Figure 2. Hepatitis seroprevalence by age.Hepatitis Monthly, Winter 2010; 10(1): 36-41
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Figure 3. Hepatitis seroprevalence by gender.
Figure 4. Seroprevalence of isolated anti-HBs and anti-HBs positive/anti-HBc positive. 
Figure 5. Isolated anti-HBs and anti-HBs positive/anti-HBc positive by age.Hepatitis Monthly, Winter 2010; 10(1): 36-41
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toto, were confirmed to be infected with HCV. The 
seroprevalence of anti-HCV among healthy people 
was 0.5%. The overall prevalence of anti-HCV did not 
differ significantly by age (P > 0.05), but differed by 
gender (P < 0.001). The prevalence of HCV infection 
was more frequently seen in females than in males (36 
females vs. 17 males). In contrast, HBV infection was 
found to be more common in males than in females 
(63.8% vs. 32%) (Fig. 3). Furthermore, the mean age 
of subjects with HBV infection was significantly lower 
than that of subjects with HCV infection (8.5±2 years 
vs. 10.1±2 years, P < 0.001). 
The  overall  percentages  for  the  prevalence  of 
isolated  anti-HBs  and  anti-HBs  positive/anti-HBc 
positive  were  34.2%  and  56.9%,  respectively.  In 
the  statistical  analyses,  anti-HBs  positive/anti-HBc 
positive and anti-HBs differed significantly by age (P 
< 0.01). As seen in Fig. 4 and 5, isolated anti-HBs 
positive  and  anti-HBs  positive/anti-HBc  positive 
prevalence was high; taking this into account, it is 
obvious that despite the high incidence of vaccinated 
children, the prevalence of hepatitis B is increasing, 
and children acquire these viruses in their early years. 
Discussion
The  prevalence  of  viral  hepatitis  and  the 
outcomes of immunization programs among 0-14 
year-olds have not been extensively studied so far 
in our region. The objective of this study was to 
determine  the  exact  seroprevalence  of  HBV  and 
HCV infections in 0-14 year-old children living in 
the endemic region of Turkey, as well as to correlate 
the serological results with the epidemiological data. 
Turkey is in a middle-endemic region (2–8%) for 
hepatitis B. According to the National Study Group, 
the national HBsAg positivity rate was found to be 
6.2% in our country, for children between 6 and 10 
years of age (6). The east and southeast region of 
Turkey is known as an endemic area for HBV infection 
in Turkey (7). We found the seroprevalence rate of 
HBsAg to be 8.1%. Previous studies performed in 
the same region revealed HBsAg a seroprevalence 
rate of between 9.5 and 11.5% (8, 9). Ucar et al. found 
HBV positivity of 4.6% and 5.2% in children aged 
6–8  and  9–12  years,  respectively  (10).  Degertekin 
investigated HBV among schoolchildren in the same 
region and found HBsAg positivity of 2%, 5% and 
7.5% in the 7, 12 and 17 year-old groups, respectively 
(11). In studies performed in southeast Turkey, the 
high prevalence of hepatitis B has been explained 
by low living conditions, low-level socioeconomic 
conditions and a high rate of vertical and horizontal 
transmission (7). In some of the previous studies, a 
low HBsAg prevalence of 4-6% has been found for 
our region, probably due to small sample sizes and 
to heterogeneous case properties such as living in 
rural areas or among schoolchildren. 
Turkey is a non-endemic area for HCV infection 
(7).  According  to  different  studies  conducted  in 
our  country,  it  has  been  reported  that  anti-HCV 
prevalence varies between 0.3 and 1.8% in blood 
donors  (12).  Prevalence  studies  conducted  in  our 
region  found  anti-HCV  in  similar  ratios.  Dursun 
et al. found an HCV prevalence of 0.4%, whereas 
Dikici et al. found a rate of 0.56% in our region (13, 
14). Emekdas et al. found the seroprevalence of HBV 
and HCV to be 4.19% and 0.38%, respectively (7). 
In the pediatrics population, among 6 to 10-year-
olds, the Turkish National Research Group found the 
anti-HBs ratio to be 12.1% (6). Demirturk et al. found 
isolated anti-HBs and isolated immunoglobulin G 
antibody to HBc (anti-HBc IgG) to be 27.2% and 
6.1% in mid-central Anatolia (15). Araz found anti-
HBs  positivity  to  be  41.7%  in  a  pediatric  group 
admitted to a pediatric hospital located in southeast 
Turkey  (16).  Isolated  anti-HBs  positive  and  anti-
HBs positive/anti-HBc positive prevalence is high 
in our study (34.2% and 56.9%). Taking all this into 
account, it is obvious that despite the high incidence 
of vaccinated children, there is an increasing number 
of  self-immune  children,  and  generally  children 
acquire  these  viruses  in  their  first  few  years  of 
life. Our observation of a gradual increase in the 
seroprevalence of anti-HBs with age is in fact an 
indicator of effective national routine vaccination 
against  hepatitis  B.  Thus,  it  is  obvious  that  the 
routine  active  vaccination  program  is  effective  in 
our region; but in spite of this vaccination program 
and the other active environmental health policies 
now being implemented in the region, hepatitis B 
continues to rise.
Most  of  the  seroepidemiological  studies  from 
Turkey  have  shown  that  horizontal  transmission 
was the major mode of transmission (2, 11, 17). Our 
observation of a high HBsAg and HBeAg prevalence 
in the first few years of life, and the high prevalence 
of anti-HBs positive/anti-HBc positive reveals that 
vertical transmission plays an important role in the 
transmission of HBV in our region. 
In Van, another big city in the region, Turkdogan 
et al. (18) found HBsAg and anti-HBs seropositivity 
as 9.5% and 44.4%, respectively. In the same region, 
Uner et al. (19) found HBs Ag seropositivity was 9.85%. 
In their study they emphasized the importance of 
vertical transmission of HBV infection in the perinatal 
period, and a lesser possibility of intrafamilial spread 
of the disease in the region. 
Data originating from HBV-screening studies of Hepatitis Monthly, Winter 2010; 10(1): 36-41
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children are not satisfactory in Turkey. In most studies, 
HBsAg  is  the  only  parameter  investigated.  There 
have been few studies comparing the prevalence of 
other hepatitis markers in our region. 
Seroepidemiological  studies  of  hepatitis  are 
necessary,  especially  in  endemic  regions,  because 
these  studies  not  only  show  us  the  regional  and 
geographical epidemiology of the disease, but also 
help  us  to  develop  regional  preventive  strategies. 
Our findings suggest that the incidence of hepatitis 
B infection is not decreasing in southeast Turkey, and 
our study reveals that the seroprevalence of HBsAg 
is higher than the averages reported in other studies 
conducted not only in the same but also in different 
regions  of  Turkey.  Significantly  high  prevalence 
of HBsAg and HBeAg positivity among children 
younger than 12 years of age is definite evidence for 
early acquisition of the infection (P < 0.001). In our 
region, nearly everyone is infected during childhood. 
Major probable causes may be due to the low quality 
of life especially in rural areas, , children living in 
crowded households, the uncontrolled movement of 
populations and the high birth rate in the region. 
Conclusions
Consequently, we have shown that HBV is still 
endemic in southeast Turkey and it has not decreased, 
as had been reported previously. Also, higher HBeAg 
positivity rates show evidence for early acquisition of 
the infection and supports the fact that in addition to 
a horizontal transmission route, vertical transmission 
plays  an  important  role  in  the  transmission  of 
hepatitis in our region. In addition, this study has 
emphasized  that  a  routine  hepatitis  immunization 
program is effective, but that targeting prophylaxis 
has failed to control HBV infection. Thus additional 
measures  are  needed.  We  suggest  an  immediate 
intervention strategy to prevent the spread of HBV 
infection.  HBV  vaccination  should  be  continued 
and HBV serological tests in pregnant women must 
be  obligatory  to  avoid  viral  vertical  transmission. 
Educational and awareness activities are necessary, 
and it is urgent that immediate effective birth control 
measures, due to the high birth rate in the region, be 
taken. Furthermore, studies like this one are needed 
for further knowledge about our success in the fight 
against hepatitis. 
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